1[1]ACC/AHA Task Force Report GuideLines for the evaluation and manage meat of heartfailure JACC ,1995,26:1376～1398 被引量：1
2[2]The task force of the working group on heart failure of the European Society of Cardiology:the Treatment of heart failure.Europen Heart J,1997,18:736～753 被引量：1
3[3]Advisory Council to Improve outcomes Nationwide in Heart Failure ,con sensus recommendations for the managemeat of chronic heart failure,Am J Cardiol,1999,83:1～30 被引量：1
4[4]packenM,conhJN,AbrahamWT,et al.Cosenus recormnendation for the managemeat of chronic heart failure,Am J Cardiol,1999,83:(2):1～38 被引量：1
5[5]The Captoril; Digoxin Malticenter Research Groap,Comparative offects of therapy with captopril and digoxin in patients with mild to moderate heart failure ,JAMA.1998,259:359～544 被引量：1
6[6]The CONSENSUS tyial study Group,Effects of enalapril on mortality in severe congestive heart faliue:Results of the cooperative North Scandi navial,Enalapril survial study (CONSENSUS) ,Nengl J Med,1987,316:1 429～1435 被引量：1
7[7]Waagstein F ,Bristly MR,Swedberg K,et al ,Beneficial effects of metoprolol in idiopathic dilated Cardiomyopathy,Lancet,1993,342:1441～1446 被引量：1
8[8]Cleland JGF,McgowanJ,ClarKA.The evidence for β3 blockers in heart failure,BMJ,1999,318:824～825 被引量：1
